Goyal RK, Chen H, Abughosh SM, Holmes HM, et al. Overall survival associated with CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer in the United States: A SEER-Medicare population-based study. Cancer 2023 Feb 9. doi: 10.1002/cncr.34675.
PMID: 36760031